LMGAM
CRL icon

Liberty Mutual Group Asset Management’s Charles River Laboratories CRL Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,541
Closed -$1.28M – 200
2018
Q3 		$1.28M Hold
9,541
– – 0.03% 275
2018
Q2 		$1.07M Buy
9,541
+213
+2% +$23K 0.03% 345
2018
Q1 		$996K Sell
9,328
-2,754
-23% -$297K 0.03% 380
2017
Q4 		$1.32M Sell
12,082
-3,123
-21% -$340K 0.04% 327
2017
Q3 		$1.64M Sell
15,205
-4,388
-22% -$451K 0.09% 231
2017
Q2 		$1.98M Sell
19,593
-1,937
-9% -$178K 0.08% 310
2017
Q1 		$1.94M Sell
21,530
-209
-1% -$17.8K 0.08% 338
2016
Q4 		$1.66M Buy
21,739
+349
+2% +$26.5K 0.06% 440
2016
Q3 		$1.78M Buy
21,390
+1,109
+5% +$93K 0.06% 377
2016
Q2 		$1.67M Buy
20,281
+1,789
+10% +$147K 0.06% 387
2016
Q1 		$1.41M Sell
18,492
-11,665
-39% -$863K 0.06% 423
2015
Q4 		$2.42M Buy
30,157
+10,231
+51% +$738K 0.1% 286
2015
Q3 		$1.27M Buy
19,926
+75
+0.4% +$5.39K 0.05% 778
2015
Q2 		$1.4M Buy
19,851
+3,791
+24% +$281K 0.05% 753
2015
Q1 		$1.27M Buy
16,060
+1,032
+7% +$76.1K 0.04% 798
2014
Q4 		$958K Sell
15,028
-149
-1% -$9.34K 0.03% 853
2014
Q3 		$907K Sell
15,177
-289
-2% -$16.5K 0.03% 882
2014
Q2 		$828K Buy
15,466
+331
+2% +$18.2K 0.03% 906
2014
Q1 		$912K Buy
15,135
+4,667
+45% +$272K 0.03% 860
2013
Q4 		$555K Sell
10,468
-4,819
-32% -$242K 0.02% 928
2013
Q3 		$707K Sell
15,287
-4,919
-24% -$226K 0.03% 765
2013
Q2 		$829K Buy
+20,206
New +$866K 0.03% 645

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Liberty Mutual Group Asset Management's CRL Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 9,541 shares — an estimated $1.28M sold.

Liberty Mutual Group Asset Management first reported a position in CRL in Q2 2013 and held it in 22 quarters. The position peaked at $2.42M in Q4 2015. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 9,541 Charles River Laboratories shares in Q4 2018, an estimated $1.28M.
  • Liberty Mutual Group Asset Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's Charles River Laboratories position peaked at $2.42M in Q4 2015.
  • 407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.